ITDOSE INFOSYSTEMS PVT. LTD.

NAME :Mrs. SAROJ GUPTA

AGE/GENDER :73 Y/Female SPECIMEN DATE :17/Jun/2025 09:06AM
TEST REQUEST ID :012506170028 SPECIMEN RECEIVED :17/Jun/2025 09:09AM
REFERRED BY :Dr. ALOK KALYANI REPORT DATE :17/Jun/2025 05:29PM

Test Name Result Ref. Range Unit

HAEMATOLOGY
COMPLETE HAEMOGRAM
Haemoglobin 11.5 12.0-15.0 gm/dl
Method:Non Cyanmeth Hb

Total Leucocyte Count 7,700 4000-11000 /cumm

Method:DC detection method

Differential Leucocyte Count

Neutrophil 89 40-75 %
Method:Microscopic

Lymphocytes 8 20-40 %
Method:Microscopic

Eosinophils 1 1-6 %
Method:Microscopic

Monocytes 2 2-10 %
Method:Microscopic

ESR (Erythrocyte Sedimentation Rate) 20 0-20 mm/1hr

Method:Modified Westergren

PCV/HCT 34.5 35-50 %

Method:Rbc pulse height detection

RBC Count 3.70 3.80-5.80 Million/cmm.

Method:DC-Detection

Platelet Count 3.10 1.5-4.5 Lakhs/cmm.

Method:DC Detection

MCV( Mean Corpuscular Volume) 93.7 80-99 fl

Method:Calculated

MCH (Mean Corpuscular Hb ) 31.3 27.0-31.0 Picogram

Method:Calculated

MCHC( Mean Corpuscular Hb 33.4 33.0-37.0 gm/dl

Concentration)
Method:Calculated

Page 1 of 8
NAME :Mrs. SAROJ GUPTA
AGE/GENDER :73 Y/Female SPECIMEN DATE :17/Jun/2025 09:06AM
TEST REQUEST ID :012506170028 SPECIMEN RECEIVED :17/Jun/2025 09:09AM
REFERRED BY :Dr. ALOK KALYANI REPORT DATE :17/Jun/2025 05:29PM

Test Name Result Ref. Range Unit

Page 2 of 8
ITDOSE INFOSYSTEMS PVT. LTD.

NAME :Mrs. SAROJ GUPTA

AGE/GENDER :73 Y/Female SPECIMEN DATE :17/Jun/2025 09:06AM
TEST REQUEST ID :012506170028 SPECIMEN RECEIVED :17/Jun/2025 09:09AM
REFERRED BY :Dr. ALOK KALYANI REPORT DATE :17/Jun/2025 05:29PM

Test Name Result Ref. Range Unit

HAEMATOLOGY
RDW-cv 15.0 11.5-14.5 %
Method:Calculated

RDW-sd 58.4 37.0-46.0 fl

Method:Calculated

Peripheral Smear
RBCs predominantly are normocytic & normochromic.
WBC series show normal total leucocyte count .Differential count
show neutrophila .
Platelets are adequate .
No immature cells / haemoparasite identified.

Impression : Neutrophilia.

Sample Type : EDTA Blood.

Done By : Erba H560 fully automated haematology analyser/Leishman Stain/Microscopy.

Interpretation :
Complete haemogram is a common blood test that provides valuable information about your overall health, focusing on different aspects of your blood composition and inflammation levels.
Here's what each component of the test typically involves:

1. Complete Blood Count (CBC):

White Blood Cell Count (WBC): Measures the total number of white blood cells, which are crucial for fighting infections and other diseases.
Red Blood Cell Count (RBC): Measures the number of red blood cells, which carry oxygen throughout the body.
Hemoglobin (Hgb): Measures the amount of oxygen-carrying protein in red blood cells.
Hematocrit (Hct): Measures the percentage of blood volume occupied by red blood cells.
Platelet Count: Measures the number of platelets, which are essential for blood clotting.

2. Erythrocyte Sedimentation Rate (ESR):

This test indirectly measures the degree of inflammation in the body.

A sample of blood is placed in a tall, thin tube and the rate at which red blood cells settle to the bottom of the tube over an hour is measured. Faster settlement
(sedimentation) is often associated with inflammation.

3. Peripheral smear examination : A peripheral smear examination, also known as a blood smear or blood film, is a diagnostic test where a thin layer of blood is spread on a microscope
slide. This allows for detailed examination of the different types of blood cells under a microscope. Here’s how the process generally works and what information it provides:

Page 3 of 8
NAME :Mrs. SAROJ GUPTA
AGE/GENDER :73 Y/Female SPECIMEN DATE :17/Jun/2025 09:06AM
TEST REQUEST ID :012506170028 SPECIMEN RECEIVED :17/Jun/2025 09:09AM
REFERRED BY :Dr. ALOK KALYANI REPORT DATE :17/Jun/2025 05:29PM

Test Name Result Ref. Range Unit

Information Provided by Peripheral Smear Examination:
Red Blood Cells (RBCs): Can reveal abnormalities such as anemia (low RBC count), presence of sickle cells, spherocytes, or parasites like malaria.
White Blood Cells (WBCs): Helps in identifying and quantifying different types of WBCs, which can indicate infections, leukemia, or other inflammatory conditions.
Platelets: Evaluates platelet count and morphology, which is important in assessing bleeding disorders or thrombocytopenia (low platelet count).
Other Findings: The smear may also reveal abnormal cells, parasites, or other conditions that are not evident from a routine blood count alone.
Clinical Uses:
Diagnosis: Helps in diagnosing various blood disorders, including anemias, infections (e.g., malaria), leukemia, and other hematologic conditions.
Monitoring: It's used to monitor treatment response in patients with blood disorders or infections.
Screening: In some cases, peripheral smear examination may be part of routine health check-ups or pre-surgical evaluations to assess overall blood health.

Peripheral smear examination is a valuable diagnostic tool that provides detailed information about the cellular components of blood and is often essential for confirming or ruling out certain
medical conditions.

Complete hemogram provides a broad overview of your blood health, including information about potential infections, anemia (low red blood cell count), clotting disorders (low platelet count),
and inflammatory conditions (elevated ESR).

Doctors use this combined information to diagnose a wide range of conditions, monitor the progression of diseases, and evaluate the effectiveness of treatments. It's a standard and informative test
in general medical practice.

Sample type : EDTA blood . Test done by 5 part automated cell counter H-560 with microscopic examination.

Page 4 of 8
ITDOSE INFOSYSTEMS PVT. LTD.

NAME :Mrs. SAROJ GUPTA

AGE/GENDER :73 Y/Female SPECIMEN DATE :17/Jun/2025 09:06AM
TEST REQUEST ID :012506170028 SPECIMEN RECEIVED :17/Jun/2025 09:09AM
REFERRED BY :Dr. ALOK KALYANI REPORT DATE :17/Jun/2025 04:02PM

Test Name Result Ref. Range Unit

BIOCHEMISTRY
SGPT(ALT)
SGPT (ALT) 15.9 0.0 - 40 U/L
Method:UV without P5P

Interpretation:

*Present in large concentrations in liver, kidney; in smaller amounts, in skeletal muscle and heart.
*Released with tissue damage, particularly liver injury. ALT is the preferred enzyme for evaluation of liver injury.

Increased in: Acute viral hepatitis (ALT > AST); Biliary tract obstruction (cholangitis,choledocholithiasis); Alcoholic hepatitis and cirrhosis (AST >
ALT); conditions - liver abscess; metastatic or primary liver cancer; non-alcoholic steatohepatitis; right heart failure; ischemia or hypoxia; injury to liver ("shock
liver"); extensive trauma. Drugs that cause cholestasis or hepatotoxicity.

Decreased in: Pyridoxine (vitamin B6) deficiency.

Sample Type: Serum

Instrument: Randox RX Imola Fully Automated Biochemistry Analyser

Page 5 of 8
ITDOSE INFOSYSTEMS PVT. LTD.

NAME :Mrs. SAROJ GUPTA

AGE/GENDER :73 Y/Female SPECIMEN DATE :17/Jun/2025 09:06AM
TEST REQUEST ID :012506170028 SPECIMEN RECEIVED :17/Jun/2025 09:09AM
REFERRED BY :Dr. ALOK KALYANI REPORT DATE :17/Jun/2025 04:03PM

Test Name Result Ref. Range Unit

IMMUNOASSAY
FREE THYROID PROFILE(FT3,FT4,TSH)
FT3 (Tri-Iodothyroxine Free) 2.340 pg/mL
Method:Electrochemiluminescence Immunoassay
Reference Range - Age Related
Cord blood: 1.5 - 3.9
1 - 4 days: 1.8 - 7.6
2 - 20 weeks: 1.85 - 7.7
5 - 24 months: 2.15 - 7.7
2 - 7 years: 2.15 - 7.7
8 - 21 years: 2.3 - 6.5
Adult (> 21 years): 2.0 - 4.4
Pregnancy: 2.0 - 3.8
FT4(Thyroxine Free) 0.720 ng/dL
Method:Electrochemiluminescence Immunoassay
Reference Range - Age Related
Cord blood: 0.9 - 2.2
1 - 4 days: 2.2 - 5.3
2 - 20 weeks: 0.9 - 2.3
5 - 24 months: 0.8 - 1.8
2 - 7 years: 1.0 - 2.1
8 - 21 years: 0.8 - 1.9
Adult (> 21 years): 0.93 - 1.7
Reference Range - Pregnancy
1
s t Trimester: 0.7 - 2.0
2 n d Trimester: 0.5 - 1.6
3 rd Trimester: 0.5 - 1.6
Interpretation:

Free T4 and Free T3 regulate normal growth and development by maintaining body temperature and stimulating calorigenesis. In addition, free T4 and free T3 affect all
aspects of carbohydrate metabolism as well as certain areas of lipid and vitamin metabolism. Elevated free T4 levels support the clinical findings of a diagnosis of
hyperthyroidism. Measurement of free T4 levels along with other thyroid tests and clinical findings can establish borderline hyperthyroid and hypothyroid diagnosis.
While normal levels of thyroid binding proteins, free T3 levels correlate with total T3. Measuring free T3 is useful when altered levels of total T3 occur due to changes
in thyroid hormone binding proteins, especially in cases with altered TBG or low albumin concentrations. Free T3 is elevated alone (T3 toxicosis) in about 5% of
hyperthyroids. Non-thyrometabolic disorders may cause abnormal free T3 levels, e.g. anticonvulsant drug therapy (Phenytoin) may result in decreased free T3 levels
due to an increased hepatic metabolism. Heparin therapy may have elevated free T3 levels.

Sample Type: Serum

Instrument: Beckman Coulter Access 2 Fully Automated Immunoassay Analyser
TSH (Thyroid Stimulating Hormone) 0.956 µIU/mL
Method:Electrochemiluminescence Immunoassay

Page 6 of 8
NAME :Mrs. SAROJ GUPTA
AGE/GENDER :73 Y/Female SPECIMEN DATE :17/Jun/2025 09:06AM
TEST REQUEST ID :012506170028 SPECIMEN RECEIVED :17/Jun/2025 09:09AM
REFERRED BY :Dr. ALOK KALYANI REPORT DATE :17/Jun/2025 04:03PM

Test Name Result Ref. Range Unit

Reference Range - Age Related

Cord blood : 1.0 - 17.4
1 - 14 days : 1.0 - 39.0
2 - 20 weeks : 1.7 - 9.1
5 - 24 months : 0.8 - 8.2
2 - 21 years : 0.7 - 5.7
Adults (>21 years) : 0.38 - 5.33
Reference Range - Pregnancy
st
1 Trimester : 0.05 - 3.7
2 nd Trimester : 0.31 - 4.35
3 rd Trimester : 0.41 - 5.18

Interpretation:

The TSH levels are inversely related to T3 & T4 levels. In primary hypothyroidism, TSH levels are high while T3 & T4 levels are low. Whereas in primary
hyperthyroidism, TSH levels are low with high T3 & T4 levels. A low T3 & T4 in the presence of low or normal TSH indicates hypothalamic or pituitary dysfunction.
A high TSH in the presence of normal or high T4 suggests inappropriate TSH secretion. INCREASED LEVELS are seen in primary hypothyroidism, inappropriate
TSH secretion, systemic illness, rarely in TSH secreting pituitary tumors (secondary hyperthyroidism). DECREASED LEVELS are seen in secondary hypothyroidism,
hyperthyroidism.

Sample Type: Serum

Instrument: Beckman Coulter Access 2 Fully Automated Immunoassay Analyser

Page 7 of 8
ITDOSE INFOSYSTEMS PVT. LTD.

NAME :Mrs. SAROJ GUPTA

AGE/GENDER :73 Y/Female SPECIMEN DATE :17/Jun/2025 09:06AM
TEST REQUEST ID :012506170028 SPECIMEN RECEIVED :17/Jun/2025 09:09AM
REFERRED BY :Dr. ALOK KALYANI REPORT DATE :17/Jun/2025 04:03PM

Test Name Result Ref. Range Unit

SEROLOGY
C-REACTIVE PROTEIN (CRP)
C-Reactive Protein (CRP) 5.6 0.0-5.0 mg/L
Method:Immunoturbidimetric Assay

Interpretation :
C - Reactive protein (CRP) is a protein which is synthesized in the liver. It is commonly referred to as acute phase reactants and provides a highly sensitive
indicator of inflammatory conditions,infections and other disease states where tissue necrosis occur. Apart from indicating inflammatory disorders, CRP
measurement also helps in differential diagnosis e.g. in the management of neonatal septicaemia & meningitis where standard microbiological investigations are
difficult. In post operative cases CRP levels invariably rise after major surgery but fall to normal within 7-10 days .
Absence of this fall is indicative of possible septic or inflammatory post operative complications.
CRP level increases significantly in case of myo-cardial infraction. CRP is found to be present after the first trimester of pregnancy untill delivery. CRP level
increases in women who are on oral contraceptives.

Result :
CRP response is not affected by the commonly used anti inflammatory or immunosuppresive drugs including steroids unless the disease activity is affected and
covers an exceptionally broad incrimental range uto 3000 times. Since CRP production is non specific in response to tissue injury, it is recommended that the result
of the test should be co-related with clinical findings to arrive at the final diagnosis.

Sample Type : Serum

-----End Of Report-----

Page 8 of 8